Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Schwarzkopf

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|December 29, 1998
Mycophenolate mofetil in ongoing chronic kidney allograft dysfunctionB Senn, P Rochat, A K Schwarzkopf, et al.
Transplantation Proceedings|December 29, 1998
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantationR P Wüthrich, T Weinreich, A K Schwarzkopf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 1999
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetilR P Wüthrich, T Weinreich, P M Ambühl, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|December 29, 1998
Mycophenolate mofetil in ongoing chronic kidney allograft dysfunctionB Senn, P Rochat, A K Schwarzkopf, et al.
Transplantation Proceedings|December 29, 1998
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantationR P Wüthrich, T Weinreich, A K Schwarzkopf, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 1999
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetilR P Wüthrich, T Weinreich, P M Ambühl, et al.
Pageof 1